Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020
BACKGROUND: Estimates of prevalence of anti-SARS-CoV-2 antibody positivity (seroprevalence) for tracking the COVID-19 epidemic are lacking for most African countriesOBJECTIVES: To determine the prevalence of antibodies against SARS-CoV-2 in a sentinel cohort of patient samples received for routine testing at tertiary laboratories in Johannesburg, South AfricaMETHODS: This sentinel study was conducted using remnant serum samples received at three National Health Laboratory Service laboratories in the City of Johannesburg (CoJ) district. Collection was from 1 August to 31 October 2020. We extracted accompanying laboratory results for glycated haemoglobin (HbAlc), creatinine, HIV, viral load and CD4 T-cell count. An anti-SARS-CoV-2 targeting the nucleocapsid (N) protein of the Coronavirus with higher affinity for IgM and IgG antibodies was used. We reported crude as well as population-weighted and test-adjusted seroprevalence. Multivariate logistic regression analysis was used to determine whether age, sex, HIV and diabetic status were associated with increased risk for seropositivityRESULTS: A total of 6 477 samples were analysed, the majority (n=5 290) from the CoJ region. After excluding samples with no age or sex stated, the model population-weighted and test-adjusted seroprevalence for the CoJ (n=4 393) was 27.0% (95% confidence interval (CI) 25.4 - 28.6). Seroprevalence was highest in those aged 45 - 49 years (29.8%; 95% CI 25.5 - 35.0) and in those from the most densely populated areas of the CoJ. Risk for seropositivity was highest in those aged 18-49 years (adjusted odds ratio (aOR) 1.52; 95% CI 1.13-2.13; p=0.0005) and in samples from diabetics (aOR 1.36; 95% CI 1.13 - 1.63;p=0.001CONCLUSIONS: Our study conducted between the first and second waves of the pandemic shows high levels of current infection among patients attending public health facilities in Gauteng Province
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
South African Medical Association
2021
|
Online Access: | http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742021001100019 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0256-95742021001100019 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0256-957420210011000192021-12-07Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020George,J AKhoza,SMayne,EDlamini,SKone,NJassat,WChetty,KCentner,C MPillay,TMaphayi,MMabuza,DMaposa,ICassini,NBACKGROUND: Estimates of prevalence of anti-SARS-CoV-2 antibody positivity (seroprevalence) for tracking the COVID-19 epidemic are lacking for most African countriesOBJECTIVES: To determine the prevalence of antibodies against SARS-CoV-2 in a sentinel cohort of patient samples received for routine testing at tertiary laboratories in Johannesburg, South AfricaMETHODS: This sentinel study was conducted using remnant serum samples received at three National Health Laboratory Service laboratories in the City of Johannesburg (CoJ) district. Collection was from 1 August to 31 October 2020. We extracted accompanying laboratory results for glycated haemoglobin (HbAlc), creatinine, HIV, viral load and CD4 T-cell count. An anti-SARS-CoV-2 targeting the nucleocapsid (N) protein of the Coronavirus with higher affinity for IgM and IgG antibodies was used. We reported crude as well as population-weighted and test-adjusted seroprevalence. Multivariate logistic regression analysis was used to determine whether age, sex, HIV and diabetic status were associated with increased risk for seropositivityRESULTS: A total of 6 477 samples were analysed, the majority (n=5 290) from the CoJ region. After excluding samples with no age or sex stated, the model population-weighted and test-adjusted seroprevalence for the CoJ (n=4 393) was 27.0% (95% confidence interval (CI) 25.4 - 28.6). Seroprevalence was highest in those aged 45 - 49 years (29.8%; 95% CI 25.5 - 35.0) and in those from the most densely populated areas of the CoJ. Risk for seropositivity was highest in those aged 18-49 years (adjusted odds ratio (aOR) 1.52; 95% CI 1.13-2.13; p=0.0005) and in samples from diabetics (aOR 1.36; 95% CI 1.13 - 1.63;p=0.001CONCLUSIONS: Our study conducted between the first and second waves of the pandemic shows high levels of current infection among patients attending public health facilities in Gauteng ProvinceSouth African Medical AssociationSAMJ: South African Medical Journal v.111 n.11 20212021-11-01journal articletext/htmlhttp://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742021001100019en |
institution |
SCIELO |
collection |
OJS |
country |
Sudáfrica |
countrycode |
ZA |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-za |
tag |
revista |
region |
África del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
George,J A Khoza,S Mayne,E Dlamini,S Kone,N Jassat,W Chetty,K Centner,C M Pillay,T Maphayi,M Mabuza,D Maposa,I Cassini,N |
spellingShingle |
George,J A Khoza,S Mayne,E Dlamini,S Kone,N Jassat,W Chetty,K Centner,C M Pillay,T Maphayi,M Mabuza,D Maposa,I Cassini,N Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020 |
author_facet |
George,J A Khoza,S Mayne,E Dlamini,S Kone,N Jassat,W Chetty,K Centner,C M Pillay,T Maphayi,M Mabuza,D Maposa,I Cassini,N |
author_sort |
George,J A |
title |
Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020 |
title_short |
Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020 |
title_full |
Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020 |
title_fullStr |
Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020 |
title_full_unstemmed |
Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020 |
title_sort |
sentinel seroprevalence of sars-cov-2 in gauteng province, south africa, august - october 2020 |
description |
BACKGROUND: Estimates of prevalence of anti-SARS-CoV-2 antibody positivity (seroprevalence) for tracking the COVID-19 epidemic are lacking for most African countriesOBJECTIVES: To determine the prevalence of antibodies against SARS-CoV-2 in a sentinel cohort of patient samples received for routine testing at tertiary laboratories in Johannesburg, South AfricaMETHODS: This sentinel study was conducted using remnant serum samples received at three National Health Laboratory Service laboratories in the City of Johannesburg (CoJ) district. Collection was from 1 August to 31 October 2020. We extracted accompanying laboratory results for glycated haemoglobin (HbAlc), creatinine, HIV, viral load and CD4 T-cell count. An anti-SARS-CoV-2 targeting the nucleocapsid (N) protein of the Coronavirus with higher affinity for IgM and IgG antibodies was used. We reported crude as well as population-weighted and test-adjusted seroprevalence. Multivariate logistic regression analysis was used to determine whether age, sex, HIV and diabetic status were associated with increased risk for seropositivityRESULTS: A total of 6 477 samples were analysed, the majority (n=5 290) from the CoJ region. After excluding samples with no age or sex stated, the model population-weighted and test-adjusted seroprevalence for the CoJ (n=4 393) was 27.0% (95% confidence interval (CI) 25.4 - 28.6). Seroprevalence was highest in those aged 45 - 49 years (29.8%; 95% CI 25.5 - 35.0) and in those from the most densely populated areas of the CoJ. Risk for seropositivity was highest in those aged 18-49 years (adjusted odds ratio (aOR) 1.52; 95% CI 1.13-2.13; p=0.0005) and in samples from diabetics (aOR 1.36; 95% CI 1.13 - 1.63;p=0.001CONCLUSIONS: Our study conducted between the first and second waves of the pandemic shows high levels of current infection among patients attending public health facilities in Gauteng Province |
publisher |
South African Medical Association |
publishDate |
2021 |
url |
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742021001100019 |
work_keys_str_mv |
AT georgeja sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT khozas sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT maynee sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT dlaminis sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT konen sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT jassatw sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT chettyk sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT centnercm sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT pillayt sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT maphayim sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT mabuzad sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT maposai sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 AT cassinin sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020 |
_version_ |
1756005993956769792 |